Paula Morzenti, MD in Apo, AE - Medicare Internal Medicine

Paula Morzenti, MD is a medicare enrolled "Internal Medicine" physician in Apo, Armed Forces Europe. Her current practice location is Cmr 402, Unit 33100, Apo, Armed Forces Europe. You can reach out to her office (for appointments etc.) via phone at (314) 590-7809.

Paula Morzenti is licensed to practice in Nebraska (license number 31605) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1255862512.

Contact Information

	Paula Morzenti, MD
	Cmr 402, Unit 33100, Apo, AE 09180
	(314) 590-7809
	Not Available

Physician's Profile

Full Name	Paula Morzenti
Gender	Female
Speciality	Internal Medicine
Location	Cmr 402, Apo, Armed Forces Europe
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1255862512
Provider Enumeration Date: 03/27/2017
Last Update Date: 02/14/2023

Medicare PECOS Information:

PECOS PAC ID: 9830525989
Enrollment ID: I20200207002086

Medical Identifiers

Medical identifiers for Paula Morzenti such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1255862512	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208D00000X	General Practice	31605 (Nebraska)	Secondary
207R00000X	Internal Medicine	31605 (Nebraska)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Paula Morzenti is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Paula Morzenti, MD Cmr 402, Unit 33100 Attn: Internal Medicine Clinic 5a, Apo, AE 09180-3100 Ph: (314) 590-7809	Paula Morzenti, MD Cmr 402, Unit 33100, Apo, AE 09180 Ph: (314) 590-7809

News Archive

Oral antibiotic shows promise to cure uncomplicated gonorrhea

An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multicenter clinical trial, according to findings published today in the New England Journal of Medicine.

Inovio achieves strong T cell immune responses in PENNVAX-B Phase I HIV study

Inovio Pharmaceuticals, Inc. announced today that it has achieved strong T cell immune responses in a Phase I clinical study of PENNVAX-B, its product for the treatment of the HIV subtype prevalent in North America and Europe, in HIV-positive subjects.

Cochlear and NXP Semiconductors sign design and manufacturing agreement

Cochlear Limited, Australian based world leader in Implantable Hearing Solutions, and NXP Semiconductors announced today that they have signed an agreement for the design and manufacturing of IC devices for Cochlear's future generation Implantable Hearing devices.

BioAlliance Pharma's new drug application for oropharyngeal candidiasis treatment accepted by the FDA

BioAlliance Pharma SA (Paris:BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that the U.S. Food and Drug Administration (FDA) has accepted the new drug application (NDA) for miconazole Lauriad® (Loramyc®) Mucoadhesive Buccal Tablets (MBT) to treat oropharyngeal candidiasis (OPC). Miconazole Lauriad® delivers the antifungal miconazole via a mucoadhesive buccal tablet that is designed to enable once-daily dosing of the active ingredient at the site of infection.

Clinical Data raises $27.8 million through common stock public offering

Clinical Data, Inc. today announced that it has raised gross proceeds of approximately $27.8 million through the public offering of 1,945,576 newly issued shares of its common stock at a price of $14.30 per share. All of the shares are being offered by Clinical Data, Inc., which exhausts all remaining shares on its existing shelf registration statement.

Internal Medicine Doctors in Apo, AE

Dr. Revati Komandur, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-7351
Brian Mccarthy, D.O. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Unit 33100, Apo, AE 09180 Phone: 314-590-4515
Dr. Alexander Sturgis Macomber Fye, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: Raf Lakenheath 48 Mdg/sghc, Unit 5115, Apo, AE 09461 Phone: 163-852-8118
Dr. Mark Anderson, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: Spangdahlem Afb, Apo, AE 09126 Phone: 496-561-618333
Dr. Bryon James Davis, DO Internal Medicine Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-5836
Dr. Zachary Charles Junga, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: Landstuhl Regional Medical Center, Unit 33100, Apo, AE 09180 Phone: 314-590-6015
Dr. Mary Jean Hamel, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: Kemri Cdc Research Station, Unit 64112, Apo, AE 09831 Phone: 254-722-772616

Paula Morzenti, MD - Medicare Internal Medicine in Apo, AE